dihydrosanguinarine has been researched along with sanguinarine chloride in 2 studies
Studies (dihydrosanguinarine) | Trials (dihydrosanguinarine) | Recent Studies (post-2010) (dihydrosanguinarine) | Studies (sanguinarine chloride) | Trials (sanguinarine chloride) | Recent Studies (post-2010) (sanguinarine chloride) |
---|---|---|---|---|---|
28 | 0 | 17 | 15 | 0 | 9 |
Protein | Taxonomy | dihydrosanguinarine (IC50) | sanguinarine chloride (IC50) |
---|---|---|---|
Ras-related C3 botulinum toxin substrate 1 | Homo sapiens (human) | 4.6 | |
Regulator of G-protein signaling 17 | Homo sapiens (human) | 1.386 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, P; Kang, W; Liu, S; Liu, W; Qing, Z; Xie, H; Zeng, J; Zhou, J | 1 |
Ding, K; Jiang, L; Lu, X; Wang, X; Wang, Y; Xu, F; Zhang, Z | 1 |
2 other study(ies) available for dihydrosanguinarine and sanguinarine chloride
Article | Year |
---|---|
Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Enzyme Activation; Humans; Inhibitory Concentration 50; Molecular Structure; Phenanthridines; Rats | 2014 |
The synthesis and biological evaluation of sanguinarine derivatives as anti-non-small cell lung cancer agents.
Topics: | 2020 |